nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2026, 17, v.67 1825-1829
张之文运用宣涤通隧、温潜归元法分期辨治慢性阻塞性肺疾病
基金项目(Foundation): 国家重点研发计划(2018YFC1704104)
邮箱(Email): fengqs118@163.com;
DOI: 10.13288/j.11-2166/r.2026.17.004
发布时间: 2026-09-01
出版时间: 2026-09-01
移动端阅读
摘要:

总结张之文教授运用宣涤通隧、温潜归元法分期辨治慢性阻塞性肺疾病(COPD)的临证经验。认为COPD核心病机为元气亏虚、三焦气化无权、经隧闭阻,提出运用宣涤通隧、温潜归元法分期辨治本病。将COPD分为急性加重期和缓解期,急性加重期治宜宣肺涤浊、疏凿通隧,选用自拟宣涤通隧方;稳定期治宜三焦同治、温潜归元,选用自拟温潜归元方。同时强调慎护微阳、忌用敛涩、纳息归根的防、治、养全病程管理原则。

Abstract:

This paper summarizes the clinical experience of professor ZHANG Zhiwen in differentiating and treating chronic obstructive pulmonary disease(COPD) at stages,with the method of diffusing and clearing to unblock the channel pathways,while warming and subduing to restore the original qi.Professor ZHANG posits that the core pathogenesis of this disease lies in depletion of original qi,leading to impaired qi transformation of sanjiao(三焦),and obstruction of channel pathways.Accordingly,a staged differentiation and treatment strategy based on the methods of diffusing and clearing to unblock the channel pathways,while warming and subduing to restore the original qi has been proposed.COPD was divided into the acute exacerbation stage and the stable stage.In acute exacerbation stage,priority is given to diffusing lung and clearing up turbidity,scatter and dredge the channel passages,using the self-formulated Xuandi Tongsui Formula(宣涤通隧方).During the stable stage,the treatment should focus on simultaneously regulating sanjiao,warming and subduing yang to restore the original qi,using the self-formulated Wenqian Guiyuan Formula(温潜归元方).In addition,the principles of carefully protecting mild yang,avoiding excessive astringent medicinals,and restoring respiration to its root are emphasized throughout the entire course of disease prevention,treatment,and rehabilitation.

参考文献

[1]吴蕾,许银姬,林琳.慢性阻塞性肺疾病中医肺康复临床应用指南[J].中医杂志,2021,62(22):2018-2024.

[2]卢瑞龙,苗玉芳,田燕歌.中医药治疗慢性阻塞性肺疾病气道重塑研究述评[J].中国中医基础医学杂志,2023,29(6):1044-1048.

[3]蒋雪莲,胡旭,钟萍,等.慢性阻塞性肺疾病患者持续性系统性炎症的前瞻性研究[J].中国呼吸与危重监护杂志,2020,19(6):536-542.

[4]许晓燕,李芳,刘若阳,等.中药干预慢性阻塞性肺疾病气道黏液高分泌作用机制研究进展[J].中成药,2025,47(9):3006-3011.

[5]杨毅.基于络病理论探析慢性阻塞性肺疾病的中医药治疗[J].医药导报,2021,40(9):1221-1224.

[6]中国中西医结合学会呼吸病专业委员会.慢性阻塞性肺疾病急性加重危险窗期中医证候诊断标准(2025)[J].中医杂志,2025,66(18):1958-1961.

[7]黄丽娜,汪伟,高峰.基于痰瘀相关理论探讨慢性阻塞性肺疾病急性加重的高凝状态[J].中医杂志,2021,62(22):1940-1943.

[8]崔红生,毕伟博.基于张仲景水饮方论谈慢性阻塞性肺疾病从肺饮论治[J].中华中医药杂志,2017,32(8):3407-3410.

[9]屈建峰,杨金生,马秀霞,等.基于“肺损络伤”探析慢性阻塞性肺疾病肺气病理变化机制[J].中国中医基础医学杂志,2023,29(7):1079-1081.

[10]陈敏,刘文平,余阳,等.张之文“调气津、开玄府、透窠囊、防癌毒”治疗肺结节经验[J].中医杂志,2024,65(14):1428-1433.

基本信息:

DOI:10.13288/j.11-2166/r.2026.17.004

中图分类号:R249;R259

引用信息:

[1]汪义明,邓剑雅,温川飙,等.张之文运用宣涤通隧、温潜归元法分期辨治慢性阻塞性肺疾病[J].中医杂志,2026,67(17):1825-1829.DOI:10.13288/j.11-2166/r.2026.17.004.

基金信息:

国家重点研发计划(2018YFC1704104)

发布时间:

2026-09-01

出版时间:

2026-09-01

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文